Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

EFTR

eFFECTOR Therapeutics (EFTR)

eFFECTOR Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:EFTR
일자시간출처헤드라인심볼기업
2024/02/2207:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EFTReFFECTOR Therapeutics Inc
2024/02/2207:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EFTReFFECTOR Therapeutics Inc
2024/02/1010:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EFTReFFECTOR Therapeutics Inc
2024/01/3022:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
2024/01/2706:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
2024/01/2706:32Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EFTReFFECTOR Therapeutics Inc
2024/01/1022:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
2024/01/1022:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
2024/01/0822:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
2024/01/0822:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
2023/12/0822:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
2023/12/0822:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
2023/11/2822:18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
2023/11/2822:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
2023/11/1406:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EFTReFFECTOR Therapeutics Inc
2023/11/1406:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
2023/09/1205:58Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
2023/09/1205:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
2023/08/0905:36Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EFTReFFECTOR Therapeutics Inc
2023/08/0905:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
2023/08/0905:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EFTReFFECTOR Therapeutics Inc
2023/08/0905:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
2023/08/0505:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
2023/08/0505:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
2023/08/0505:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
2023/06/2719:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EFTReFFECTOR Therapeutics Inc
2023/06/2405:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EFTReFFECTOR Therapeutics Inc
2023/06/0819:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EFTReFFECTOR Therapeutics Inc
2023/06/0819:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EFTReFFECTOR Therapeutics Inc
2023/06/0819:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:EFTReFFECTOR Therapeutics Inc
 검색 관련기사 보기:NASDAQ:EFTR